Mechanisms involved in suppression of NGF-induced neuronal differentiation of PC12 cells by hyaluronic acid

Experimental Cell Research

Volumn 315, Issue 17, 2009, Pages 3036-3043

  Washio, Ayako ^a   Kitamura, Chiaki ^a   Jimi, Eijiro ^a   Terashita, Masamichi ^a   Nishihara, Tatsuji ^a  

^a KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

Hyaluronic acid; Neuronal differentiation; NGF; PC12

Indexed keywords

CELL PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYALURONIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; PROTEIN ANTIBODY; PROTEIN RHAMM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 70349439007     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.07.006     Document Type: Article

References (44)

1. Nandini C.D., Itoh N., and Sugahara K. Novel 70-kDa chondroitin sulfate/dermatan sulfate hybrid chains with a unique heterogeneous sulfation pattern from shark skin, which exhibit neuritogenic activity and binding activities for growth factors and neurotrophic factors. J. Biol. Chem. 280 (2005) 4058-4069
2. Mah J. Histochemistry of the foetal human temporomandibular joint articular disc. Eur. J. Orthod. 26 (2004) 359-365
3. Zhu J., Li Y., Shen W., Qiao C., Ambrosio F., Lavasani M., Nozaki M., Branca M.F., and Huard J. Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J. Biol. Chem. 282 (2007) 25852-25863
4. Deiters B., and Prehm P. Inhibition of hyaluronan export reduces collagen degradation in interleukin-1 treated cartilage. Arthritis Res. Ther. 10 (2008) 1-9
5. Hikino M., Mikami T., Faissner A., Vilela-Silva A.C., Pavão M.S., and Sugahara K. Oversulfated dermatan sulfate exhibits neurite outgrowth-promoting activity toward embryonic mouse hippocampal neurons: implications of dermatan sulfate in neuritogenesis in the brain. J. Biol. Chem. 278 (2003) 43744-43754
6. Iwata M., Wight T.N., and Carlson S.S. A brain extracellular matrix proteoglycan forms aggregates with hyaluronan. J. Biol. Chem. 268 (1993) 15061-15069
7. Sirko S., von Holst A., Wizenmann A., Götz M., and Faissner A. Chondroitin sulfate glycosaminoglycans control proliferation, radial glia cell differentiation and neurogenesis in neural stem/progenitor cells. Development 134 (2007) 2727-2738
8. Bartlett A.H., Hayashida K., and Park P.W. Molecular and cellular mechanisms of syndecans in tissue injury and inflammation. Mol. Cells 24 (2007) 153-166
9. Oohira A., Katoh-Semba R., Watanabe E., and Matsui F. Brain development and multiple molecular species of proteoglycan. Neurosci. Res. 20 (1994) 195-207
10. Bovolenta P., and Fernaud-Espinosa I. Nervous system proteoglycans as modulators of neurite outgrowth. Prog. Neurobiol. 61 (2000) 113-132
11. Gotoh S., Onaya J., Abe M., Miyazaki K., Hamai A., Horie K., and Tokuyasu K. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann. Rheum. Dis. 52 (1993) 817-822
12. Takahashi K., Goomer R.S., Harwood F., Kubo T., Hirasawa Y., and Amiel D. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta (IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthr. Cartil. 7 (1999) 182-190
13. Toole B.P. Hyaluronan is not just a goo!. J. Clin. Invest. 106 (2000) 335-336
14. Ariyoshi W., Takahashi T., Kanno T., Ichimiya H., Takano H., Koseki T., and Nishihara T. Mechanism involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid. J. Biol. Chem. 280 (2005) 18967-18972
15. Liesegang T.J. Viscoelastic substances in ophthalmology. Surv. Ophthalmol. 34 (1990) 268-293
16. Fukuda K., Dan H., Takayama M., Kumano F., Saitoh M., and Tanaka S. Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1. J. Pharmacol. Exp. Ther. 277 (1996) 1672-1675
17. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 2424-2428
18. Kaplan D.R., Martin-Zanca D., and Parada L.F. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350 (1991) 158-160
19. Snow D.M., and Letourneau P.C. Neurite outgrowth on a step gradient of chondroitin sulfate proteoglycan (CS-PG). J. Neurobiol. 23 (1992) 322-336
20. Shinmyouzu K., Takahashi T., Ariyoshi W., Ichimiya H., Kanzaki S., and Nisihihara T. Dermatan sulfate inhibits osteoclast formation by binding to receptor activator of NF-kappa B ligand. Biochem. Biophys. Res. Commun. 354 (2007) 447-452
21. Davis R.J. MAPKs: new JNK expands the group. Trends Biochem. Sci. 19 (1994) 470-473
22. Iwasaki S., Hattori A., Sato M., Tsujimoto M., and Kohno M. Characterization of the bone morphogenetic protein-2 as a neurotrophic factor. Induction of neuronal differentiation of PC12 cells in the absence of mitogen-activated protein kinase activation. J. Biol. Chem. 271 (1996) 17360-17365
23. Vaudry D., Stork P.J., Lazarovici P., and Eiden L.E. Signaling pathways for PC12 cell differentiation: making the right connections. Science 296 (2002) 1648-1649
24. Sasagawa S., Ozaki Y., Fujita K., and Kuroda S. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat. Cell Biol. 7 (2005) 365-373
25. Sun P., Watanabe H., Takano K., Yokoyama T., Fujisawa J., and Endo T. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells. Genes Cells 11 (2006) 1097-1113
26. Santos S.D., Verveer P.J., and Bastiaens P.I. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 9 (2007) 324-330
27. Morooka T., and Nishida E. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J. Biol. Chem. 273 (1998) 24285-24288
28. Nishina A., Kimura H., Sekiguchi A., Fukumoto R., Nakajima S., and Furukawa S. Lysophosphatidylethanolamine in Grifola frondosa as a neurotrophic activator via activation of MAPK. J. Lipid Res. 47 (2006) 1434-1443
29. Harada T., Morooka T., Ogawa S., and Nishida E. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat. Cell Biol. 3 (2001) 453-459
30. Xing J., Kornhauser J.M., Xia Z., Thiele E.A., and Greenberg M.E. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol. Cell. Biol. 18 (1998) 1946-1955
31. Deak M., Clifton A.D., Lucocq J.M., and Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17 (1998) 4426-4441
32. Kim Y., Seger R., Suresh Babu C.V., Hwang S.Y., and Yoo Y.S. A positive role of the PI3-K/Akt signaling pathway in PC12 cell differentiation. Mol. Cells 18 (2004) 353-359
33. Chang J.H., Vuppalanchi D., van Niekerk E., Trepel J.B., Schanen N.C., and Twiss J.L. PC12 cells regulate inducible cyclic AMP (cAMP) element repressor expression to differentially control camp response element-dependent transcription in response to nerve growth factor and cAMP. J. Neurochem. 99 (2006) 1517-1530
34. Lonzw B.E., and Ginty D.D. Function and regulation of CREB family transcription factors in the nervous system. Neuron 35 (2002) 605-623
35. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
36. 2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blocking of the MAPK cascade. J. Biol. Chem. 277 (2002) 33930-33942
37. Turley E.A. Purification of a hyaluronate-binding protein fraction that modifies cell social behavior. Biochem. Biophys. Res. Commun. 108 (1982) 1016-1024
38. Turley E.A., Noble P.W., and Bourguignon Y.W. Signaling properties of hyaluronan receptors. J. Biol. Chem. 277 (2002) 4589-4592
39. Nagy J.I., Hacking J., Frankenstein U.N., and Turley E.A. Requirement of the hyaluronan receptor RHAMM in neurite extension and motility as demonstrated in primary neurons and neuronal cell lines. J. Neurosci. 15 (1995) 241-252
40. Lynn B.D., Li X., Cattini P.A., and Nagy J.I. Sequence, protein expression and extracellular-regulated kinase association of the hyaladherin RHAMM (receptor for hyaluronan mediated motility) in PC12 cells. Neurosci. Lett. 306 (2001) 49-52
41. Zhang S., Chang M.C.Y., Zylka D., Turley S., Harrison R., and Turley E.A. The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J. Biol. Chem. 273 (1998) 11342-11348
42. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., and Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279 (2004) 17079-17084
43. del Fresno C., Otero K., Gómez-García L., González-León M.C., Soler-Ranger L., Fuentes-Prior P., Escoll P., Baos R., Caveda L., García F., Arnalich F., and López-Callazo E. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J. Immunol. 174 (2005) 3032-3040
44. Gariboldi S., Palazzo M., Zanobbio L., Selleri S., Sommariva M., Sfondrini L., Cavicchini S., Balsari, and Rumio C. Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of β-defensin 2 via TLR2 and TLR4. J. Immunol. 181 (2008) 2103-2110